Gossamer Bio, Inc. (GOSS)

0.5604 +0.09 (+19.23%) USD  |  NASDAQ  |  Mar 04, 14:43
More

Gossamer Bio Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade